These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 11363362)

  • 21. Oxandrolone, an anabolic steroid, significantly increases the rate of weight gain in the recovery phase after major burns.
    Demling RH; DeSanti L
    J Trauma; 1997 Jul; 43(1):47-51. PubMed ID: 9253907
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacologic management of anorexia/cachexia.
    Ottery FD; Walsh D; Strawford A
    Semin Oncol; 1998 Apr; 25(2 Suppl 6):35-44. PubMed ID: 9625382
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The anabolic androgenic steroid oxandrolone in the treatment of wasting and catabolic disorders: review of efficacy and safety.
    Orr R; Fiatarone Singh M
    Drugs; 2004; 64(7):725-50. PubMed ID: 15025546
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Approaches to the AIDS Wasting Syndrome.
    Corcoran C
    Posit Dir News; 1998; 10(2):24-7. PubMed ID: 11365549
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Summaries for patients. Oxandrolone treatment for pressure ulcers.
    Ann Intern Med; 2013 May; 158(10):I-20. PubMed ID: 23833788
    [No Abstract]   [Full Text] [Related]  

  • 26. Building your body to survive: the use of anabolic steroids for HIV therapy.
    Vergel N
    Posit Aware; 1998; 9(2):37-41. PubMed ID: 11365225
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New drug to treat wasting syndrome.
    Common Factor; 1995 Apr; (no 10):19. PubMed ID: 11362344
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIV-associated wasting: brief review and discussion of the impact of oxandrolone.
    Taiwo BO
    AIDS Patient Care STDS; 2000 Aug; 14(8):421-5. PubMed ID: 10977971
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Wasting. Anabolic steroid helps women gain weight.
    TreatmentUpdate; 2005; 17(4):3-4. PubMed ID: 17228467
    [No Abstract]   [Full Text] [Related]  

  • 30. Wasting syndrome--affordable treatments.
    James JS
    AIDS Treat News; 1995 Jul; (no 226):6-7. PubMed ID: 11362615
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An update on promising agents for the treatment of cancer cachexia.
    Madeddu C; Mantovani G
    Curr Opin Support Palliat Care; 2009 Dec; 3(4):258-62. PubMed ID: 19667995
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Appetite stimulants and anabolic steroid therapy for AIDS wasting.
    Saseen J; MacLaughlin EJ
    AIDS Read; 1999 Sep; 9(6):398, 401-2, 407. PubMed ID: 12737131
    [No Abstract]   [Full Text] [Related]  

  • 33. A beneficial effect of oxandrolone in the treatment of Duchenne muscular dystrophy: a pilot study.
    Fenichel G; Pestronk A; Florence J; Robison V; Hemelt V
    Neurology; 1997 May; 48(5):1225-6. PubMed ID: 9153447
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of early puberty in a boy after treatment with oxandrolone?
    Doeker B; Müller-Michaels J; Andler W
    Horm Res; 1998; 50(1):46-8. PubMed ID: 9691214
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oxandrolone steroid use and impaired coagulation.
    Koller EA; Wei X; Johnson TE
    Arch Intern Med; 2006 Jan; 166(1):125. PubMed ID: 16401821
    [No Abstract]   [Full Text] [Related]  

  • 36. The rate of restoration of body weight after burn injury, using the anabolic agent oxandrolone, is not age dependent.
    Demling RH; DeSanti L
    Burns; 2001 Feb; 27(1):46-51. PubMed ID: 11164665
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the effects of oxandrolone on malnourished HIV-positive pediatric patients.
    Fox-Wheeler S; Heller L; Salata CM; Kaufman F; Loro ML; Gilsanz V; Haight M; Umman GC; Barton N; Church JA
    Pediatrics; 1999 Dec; 104(6):e73. PubMed ID: 10586007
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oxandrolone in the treatment of HIV-associated weight loss in men: a randomized, double-blind, placebo-controlled study.
    Grunfeld C; Kotler DP; Dobs A; Glesby M; Bhasin S
    J Acquir Immune Defic Syndr; 2006 Mar; 41(3):304-14. PubMed ID: 16540931
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New treatment available for AIDS cachexia.
    Hoyt G
    Surviv News (Atlanta Ga); 2003; ():7. PubMed ID: 14666919
    [No Abstract]   [Full Text] [Related]  

  • 40. Relationship between body composition and cytokines in cachectic patients with chronic obstructive pulmonary disease.
    Yeh SS; Hafner A; Schuster MW; Mantovani G; Levine DM; Parker TS
    J Am Geriatr Soc; 2003 Jun; 51(6):890-1. PubMed ID: 12757590
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.